Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst

William Blair starts Natera coverage, citing MRD growth potential, strong moat, and diversified pipeline supporting long-term outlook. Latest Ratings for NTRA Date Firm Action From To Mar 2022 Goldman Sachs Initiates Coverage On Buy Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Baird Maintains Outperform View More Analyst Ratings for NTRA View the Latest Analyst Ratings Importance Rank: 1 read more

Go to News Site